Yet they were able to do CR from big investors at higher price, the recent was $80M at 20c since another important factor of regulatory approval for biotech start-up is the chance of commercialisation success and there's no arguing the market potential is extreme for IMU which explains the high MC and also having nearly $200M in cash as well.
Why IMU is a multi multi bagger, page-10222
-
- There are more pages in this discussion • 15,732 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
